In this study, our goal was to elucidate the therapeutic potential of ILA in a PD mouse model by identifying specific ILA stimulation parameters, such as wavelength, that are effective in improving behavioral outcomes and protecting nigrostriatal dopaminergic neurons. This evidence concerns the gene TNFRSF9 and Parkinson disease.